about
Asthma in pregnancy and its pharmacologic treatmentUse of a job-exposure matrix to assess occupational exposures in relation to birth defectsEpidemiology of ischemic placental disease: a focus on preterm gestationsNonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newbornSpatial analysis of gastroschisis in Massachusetts and TexasFindings on potential teratogens from a case-control study in Western AustraliaMaternal medication use and risks of gastroschisis and small intestinal atresiaSpatial analysis of gastroschisis in the National Birth Defects Prevention StudySeasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birthMaternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007.Application of data screening to drug exposure in large risk factor studies of birth defects.Fruit and vegetable intake and risk of upper respiratory tract infection in pregnant womenPrenatal screening for clubfoot: what factors predict prenatal detection?Maternal dietary glycemic intake and the risk of neural tube defectsFolic acid antagonists during pregnancy and the risk of birth defects.Medication use in pregnancy in relation to the risk of isolated clubfoot in offspringAssessment of antihistamine use in early pregnancy and birth defectsMaternal genitourinary infections and the risk of gastroschisis.Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.Health-related quality of life in children with hemifacial microsomia: parent and child perspectives.Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.Nausea and vomiting during pregnancy and neurodevelopmental outcomes in offspring.Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis.Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.Corticosteroid use and risk of orofacial clefts.Congenital Malformations and Consequential Epidemiology.Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.Neurodevelopmental outcomes in children with hemifacial microsomia.Society for pediatric and perinatal epidemiologic research annual meeting: looking back, looking forward.Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study.Maternal periconceptional exposure to cigarette smoking and congenital limb deficiencies.Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.Periconceptional use of opioids and the risk of neural tube defects.Comparison of web versus interview participants in a case-control study.Is it worthwhile to routinely ultrasound screen children with idiopathic clubfoot for hip dysplasia?Parker et al. Respond to "Preeclampsia Risk After Induced Abortion"Predictors of recall certainty of dates of analgesic medication use in pregnancy.Maternal dietary glycaemic intake during pregnancy and the risk of birth defectsPsychosocial outcomes in children with and without non-syndromic craniosynostosis: findings from two studies
P50
Q24633071-57088D87-3FDC-4DF0-9212-954129B94604Q26340715-1920BF7B-02DC-42A3-ADA4-0ACBD7DC657AQ26828578-820C5207-B488-4840-A414-3CA0B38A78B3Q27026121-40CD4E48-83F9-4D93-8E3D-8EFC0510A77AQ27333521-43841240-9787-491A-8458-D83ECDF33750Q28166703-DD7F3AE3-0185-4053-8BF4-2182479035D5Q28192006-C1E915D4-9AC6-4ED9-832D-867B52BABBAAQ28397028-B71407A7-4E52-4120-A4EE-4E6AB6CBE7CCQ30367964-19959846-DBFC-4A8A-84C4-E60FF6A2D0D3Q30620024-43490DC6-DB3A-44F5-80C0-9BB7B7D52619Q30986274-6B15EACB-AC83-4F3A-B3E6-5627870ADE5CQ33598681-63FED9EC-25F4-4922-9F56-2C6601117735Q33637939-970B4816-B536-4F7F-81EB-D9C796C32E26Q33741421-6D77D077-8492-4125-B0B9-8F8DC70A0170Q33926560-FF7F8449-87EE-4D95-9FD1-676288643DC1Q34048103-D3515940-EB53-4397-A750-F5EFBE9C00E5Q34075092-6A62B559-BA8F-4594-B4E7-46E436558619Q34083074-44726E53-8205-481A-A794-BF712B9B8D86Q34270366-14AF6195-B2D4-4F22-B946-4B55898666A6Q34445277-28FC164F-DDBF-470E-B7FF-3D8F087938E2Q34492967-042EA70C-86E9-42B7-85D9-71E5078BD02EQ34516979-96DB94D5-4034-4E60-B26E-F2A834BE7F82Q34572873-1CCE6651-0AF7-4DB5-BD51-5431B832A877Q34616956-09A698AF-4377-48AA-84FD-CAB7F5325709Q34642517-5BD6A1D2-3C8A-4064-B2EA-55E8B4EFC711Q34819115-8920061E-0BF4-4CE9-A0A1-8BA65D4B43DDQ35077898-DE46EA58-7B18-4704-9364-1020797A3DCEQ35116653-7DFE10F3-0B3E-48E5-9D3C-F3AF22311249Q35125236-99AD9C29-A094-4206-8A5E-128562B4EBEAQ35131854-6041DD3C-92CF-4D07-8976-3CFE0122BC24Q35449939-DD9B7CE5-121F-410B-A840-5DEC4223EF2AQ35653403-B840B24F-D136-4480-8785-CEC255637DD9Q35820722-1A7680DD-FCDC-42D4-A81B-9ADADC4EFB9CQ36019888-01681037-2B43-4FD9-874C-4AFFE27BFA1CQ36054227-BCA641B5-AB6E-40BC-8C94-5119A9F78778Q36070961-F3B8460F-966A-4FE4-A846-A4BF29DEC0BCQ36135790-193B3FED-5CCA-4A4A-9AF7-637BFC425FAFQ36237479-E0DE89A8-BED3-422F-830D-605DDF839CDAQ36327010-56BAF6DB-7E8E-4C0E-99E6-B91D190D10EAQ36331243-7E06E70F-60C6-4FCC-A2CA-3D3D08A759D5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martha M Werler
@ast
Martha M Werler
@en
Martha M Werler
@es
Martha M Werler
@nl
Martha M Werler
@sl
type
label
Martha M Werler
@ast
Martha M Werler
@en
Martha M Werler
@es
Martha M Werler
@nl
Martha M Werler
@sl
prefLabel
Martha M Werler
@ast
Martha M Werler
@en
Martha M Werler
@es
Martha M Werler
@nl
Martha M Werler
@sl
P106
P21
P31
P496
0000-0003-3392-6814